
Journal of Medicinal Chemistry p. 1466 - 1473 (1982)
Update date:2022-07-30
Topics:
Hirai
Fujishita
Ishiba
Sugimoto
Matsutani
Tsukinoki
Hirose
A series of the title compounds was prepared via condensation of the 3-(aminomethyl)triazolylbenzophenone with N-protected amino acids, followed by deprotection, amination of the 3-[(chloroacetamido)methyl]triazolylbenzophenone, or reduction of the relevant azide derivative. Some of the title compounds were also derived directly from the quinazolines by acid-induced rearrangement, followed by deprotection. These new amino acid amide derivatives of the triazolylbenzophenones were evaluated for central nervous system (CNS) activity. Members of this class of compounds exhibited a high level of CNS activities. For example, 2',5-dichloro-2-[3-[(glycylamino)methyl]-5-methyl-4H-1,2,4-triazol-4-yl ]benzophenone was as active as triazolam, with an ED50 of 0.58 mg/kg (mice, po), against antifighting activity in the foot shock-induced fighting test. Other triazolylbenzophenone derivatives showed similar pharmacological activities.
View MoreShanghai Longjin Metallic Material Co., Ltd.
website:http://www.shlongjin.cn/
Contact:021-56517503,56502257
Address:No.16, Lane 555, Chengyin Road, Shanghai
Contact:+44 7958 511245
Address:PO Box 469, Manchester, UK
Lanzhou huibang biological chemical technology Co., LTD
Contact:0931-7843964
Address:NO.2011,Yannan Road,Chengguan,
Shanghai Yuking Water Soluble Material Tech Co., Ltd
Contact:86-21-68286299
Address:4F, 13B, No. 600, South Xinyuan Road 201306, Shanghai, China
Contact:86-28-61993785
Address:No.70-13-21, North Section, Erhuan
Doi:10.1039/c9gc01554j
(2019)Doi:10.1021/acs.oprd.6b00035
(2016)Doi:10.1016/j.jorganchem.2007.11.020
(2008)Doi:10.1016/j.tet.2007.11.097
(2008)Doi:10.1021/ja076801k
(2008)Doi:10.1016/j.bmc.2010.12.007
(2011)